Global dengue vaccine market is expected to grow over the forecast period owing to frequent incidences of dengue infections in tropical and sub-tropical regions, and increased government funding to develop vaccines. According to World Health Organization (WHO), 50 to 100 Mn dengue infections occur yearly. In addition, market players are actively involved in partnerships with NGO’s and government organisations, few vaccines are under clinical trials and rise in medical insurance in developing countries are anticipated to drive the market over the forecast period. However, lack or insufficient healthcare infrastructure in underdeveloped and developing regions leading to serious medical conditions going unnoticed. Furthermore, lack of awareness related to symptoms and high cost of vaccine development are hindering the dengue vaccine market.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Dengue vaccine market segmented on the basis of vaccine type and end-user
Based on vaccine type, dengue vaccine market is segmented into
Live- Attenuated Vaccines
Purified Inactivated Vaccines
Based on end-user, dengue vaccine market is segmented into
Hospitals
Clinics
Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-c654SbFYO64MsOhu[/URL]
Dengue vaccine market is expected to grow at a significant rate during the forecast period. Market players are focusing on the development of dengue vaccines which are in different stages of development to grab the market share. For instance, TDEN PIV, a tetravalent purified inactivated vaccine for prevention of dengue, currently being developed jointly by alter Reed Army Institute of Research (WRAIR) and GSK in phase -1 clinical study. Similarly, TDV is a live attenuated vaccine that is being developed in phase-3 clinical trials by Takeda Pharmaceuticals. Furthermore, many research institutions such as Bhutantan Institute, Griffith University are involved in development of dengue vaccine. Government and non-government organizations initiating many programs and activities to increase vaccines usage and awareness among the people.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the market players in Dengue Vaccine Market include Sanofi (France), GlaxoSmithKline Plc (London), Takeda Pharmaceutical Company Ltd (Japan), Merck & Co Inc. (U.S.), Instituto Butantan (Brazil), and VABIOTECH (Vietnam) to name a few.